Mealey's begins Thimerosal & Vaccines report.
Marketing manager Lex Daniele said, "One of the hottest areas in drug product liability litigation today concerns the use of thimerosal in vaccines. A number of lawsuits have been filed across the country regarding this mercury-containing preservative. These lawsuits assert a variety of resulting illnesses, the most prominent or which is autism."
The new monthly report- priced at $800/year-covers recently filed lawsuits, the latest unearthed discovery, updates on medical studies, defenses, novel theories of recovery, medical monitoring claims, vaccine industry briefs, and more.
The report tracks important litigation news as it occurs in state and federal trial courts, as well as the National Vaccine Injury Compensation Program.
An online version and e-mail delivery are also available.
Mealey's publishes more than 40 litigation reports.
P.O. Box 62090. King of Prussia, PA 19406, 610- 768-7800, fax 610-768-0880, www.mealeys.com
|Printer friendly Cite/link Email Feedback|
|Publication:||The Newsletter on Newsletters|
|Date:||Jul 31, 2002|
|Previous Article:||Phillips investment unveils PortfolioGrader.com. (Launches).|
|Next Article:||Four publishers offer insights into running a business in uncertain times. (Management).|